In both melanoma (Fig. 4e) and breast cancer (Fig. 4f), patients with azu-positive tumors had better overall survival times than patients with azu-negative tumors, suggesting that P. aeruginosa azurin positively affects the prognosis of patients, at least for those with melanoma or breast cancer. The gene discussed is AZU1; the disease is breast cancer.